NFE2L3 and adrenal cortex carcinoma: Our study showed that NFE2L3 expression correlated with the clinicopathological stages (stages I, II, III, IV, and X) of eight tumors, including ACC, CESC, KIRC, OV, PAAD, THCA, LIHC, and BRCA (Figure 3A).